Dexpanthenol/Sodium Hyaluronate
右泛醇/透明质酸钠
Report date: 2025/07/30 14:54:07
Base Information
Drug NameDexpanthenol/Sodium Hyaluronate
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes DexpanthenolSodium Hyaluronate
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Sophia Sa De Cv
China Registration ClassN/A
Develop Information
Active CompaniesLaboratorios Sophia Sa De Cv
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A